Ticker

LONDON'S GLOBAL INFLUENCE ON TRAVEL AND HOSPITALITY TAKES CENTER STAGE AT TWO-DAY SUMMIT NEW YORK, Sept. 14, 2026 /PRNewswire/ -- Travel + Leisure, a People Inc. brand, will bring its World's Best Summit to London for the first time on October 27 and 28, 2026.

Opus Genetics receives a Buy rating following >30% stock surge on positive Phase 1/2 data for OPGx-BEST1 in BEST1-related retinal diseases. OPGx-BEST1 showed clinically meaningful visual improvements and strong safety in all Cohort 1 patients, with greater gains in less advanced disease. IRD's pipeline targets large, underserved markets with no approved therapies; cash runway extends into 2029, supporting ongoing…

Opus Genetics, Inc. (IRD) Discusses Topline Results From Cohort 1 of BEST1 Phase I/II Gene Therapy Trial Transcript

OPGx-BEST1 demonstrated a favorable safety and tolerability profile with no serious adverse events or dose-limiting toxicities observed  All five participants demonstrated clinically meaningful improvement in visual function, with structural improvements observed in four participants FDA aligned on ≥3 decibels microperimetry improvement in conjunction with patient reported outcomes as a potential pivotal endpoint…

Bruker Energy and Supercon Technologies (BEST), a segment of [url="]Bruker Corporation[/url] (Nasdaq: BRKR), and Luvata Materials and Solutions, a Business Unit of